183 related articles for article (PubMed ID: 29988144)
1. A path to efficient gene editing.
Urnov FD
Nat Med; 2018 Jul; 24(7):899-900. PubMed ID: 29988144
[No Abstract] [Full Text] [Related]
2. CRISPR: Stressed about p53?
Foronda M; Dow LE
Trends Mol Med; 2018 Sep; 24(9):731-733. PubMed ID: 30017531
[TBL] [Abstract][Full Text] [Related]
3. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
Wang YD; Liang QF; Li ZY; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
[TBL] [Abstract][Full Text] [Related]
4. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
5. Reply to "CRISPR screens are feasible in TP53 wild-type cells".
Haapaniemi E; Botla S; Persson J; Schmierer B; Taipale J
Mol Syst Biol; 2019 Aug; 15(8):e9059. PubMed ID: 31464368
[TBL] [Abstract][Full Text] [Related]
6. Genome editing: The efficient tool CRISPR-Cpf1.
Mahfouz MM
Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
[No Abstract] [Full Text] [Related]
7. The Implications of CRISPR-Cas9 Genome Editing for IR.
Perkons NR; Sheth R; Ackerman D; Chen J; Saleh K; Hunt SJ; Nadolski GJ; Shi J; Gade TP
J Vasc Interv Radiol; 2018 Sep; 29(9):1264-1267.e1. PubMed ID: 30146193
[No Abstract] [Full Text] [Related]
8. p53 Throws CRISPR a Curve.
Carroll D
Trends Pharmacol Sci; 2018 Sep; 39(9):783-784. PubMed ID: 30006230
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
10. Genome editing: CRISPR-Cas becoming more human.
Baumann K
Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
[No Abstract] [Full Text] [Related]
11. CRISPR-Cas in its prime.
Zlotorynski E
Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
[No Abstract] [Full Text] [Related]
12. Gene Editing for the Heart: Correcting Dystrophin Mutations.
McNally EM
Circ Res; 2017 Sep; 121(8):896-898. PubMed ID: 28963182
[TBL] [Abstract][Full Text] [Related]
13. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
14. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
15. From CRISPR scissors to virus sensors.
Kocak DD; Gersbach CA
Nature; 2018 May; 557(7704):168-169. PubMed ID: 29730672
[No Abstract] [Full Text] [Related]
16. Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.
Li S; Zhang X; Wang W; Guo X; Wu Z; Du W; Zhao Y; Xia L
Mol Plant; 2018 Jul; 11(7):995-998. PubMed ID: 29567453
[No Abstract] [Full Text] [Related]
17. No apparent p53 activation in CRISPR-engineered gene-edited rabbits.
Zhang T; Li J; Wang T; Zhao F; Sui T
J Cell Mol Med; 2021 Nov; 25(21):10313-10317. PubMed ID: 34609046
[TBL] [Abstract][Full Text] [Related]
18. Next-generation diagnostics with CRISPR.
Chertow DS
Science; 2018 Apr; 360(6387):381-382. PubMed ID: 29700254
[No Abstract] [Full Text] [Related]
19. Multiplex gene editing in rice with simplified CRISPR-Cpf1 and CRISPR-Cas9 systems.
Wang M; Mao Y; Lu Y; Wang Z; Tao X; Zhu JK
J Integr Plant Biol; 2018 Aug; 60(8):626-631. PubMed ID: 29762900
[TBL] [Abstract][Full Text] [Related]
20. [Recent progresses in CRISPR genome editing in plants].
Li H; Xie K
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]